Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Mar 31, 2026
Purchase
Shares
411
Price
$32.60
Total Value
$13.40K
Shares Held After
146,657
% of Holdings
0.3%
Mar 31, 2026
Purchase
Shares
1,957
Price
$31.45
Total Value
$61.55K
Shares Held After
146,657
% of Holdings
1.3%
Mar 31, 2026
Purchase
Shares
186
Price
$30.48
Total Value
$5.67K
Shares Held After
146,657
% of Holdings
0.1%
Mar 31, 2026
Purchase
Shares
17
Price
$27.78
Total Value
$472.32
Shares Held After
146,657
% of Holdings
0.0%
Mar 31, 2026
Purchase
Shares
1,048
Price
$26.73
Total Value
$28.01K
Shares Held After
146,657
% of Holdings
0.7%
Mar 31, 2026
Purchase
Shares
1,770
Price
$25.32
Total Value
$44.82K
Shares Held After
146,657
% of Holdings
1.2%
Mar 31, 2026
Purchase
Shares
616
Price
$24.69
Total Value
$15.21K
Shares Held After
146,657
% of Holdings
0.4%
Mar 31, 2026
Purchase
Shares
789
Price
$2.54
Total Value
$2.00K
Shares Held After
818
% of Holdings
96.5%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
3,768
Price
$18.63
Total Value
$70.20K
Shares Held After
426,736
% of Holdings
0.9%
Mar 31, 2026
Purchase
Shares
520
Price
$10.60
Total Value
$5.51K
Shares Held After
1,538,296
% of Holdings
0.0%

Processa Pharmaceuticals, Inc. (PCSA)

Guy Wendy — Chief Administrative Officer
Mar 31, 2026
Purchase
Shares
1,854
Price
$2.54
Total Value
$4.70K
Shares Held After
3,110
% of Holdings
59.6%
Mar 31, 2026
Purchase
Shares
2,136
Price
$2.54
Total Value
$5.41K
Shares Held After
3,649
% of Holdings
58.5%

Processa Pharmaceuticals, Inc. (PCSA)

Lin Patrick — Chief Business - Strategy Off
Mar 31, 2026
Purchase
Shares
1,603
Price
$2.54
Total Value
$4.06K
Shares Held After
3,356
% of Holdings
47.8%
Mar 31, 2026
Purchase
Shares
1,810
Price
$2.54
Total Value
$4.59K
Shares Held After
10,562
% of Holdings
17.1%
Mar 31, 2026
Purchase
Shares
2,072
Price
$2.54
Total Value
$5.25K
Shares Held After
2,188
% of Holdings
94.7%

Processa Pharmaceuticals, Inc. (PCSA)

SKIBSTED RUSSELL — Chief Financial Officer
Mar 31, 2026
Purchase
Shares
2,324
Price
$2.54
Total Value
$5.89K
Shares Held After
2,324
% of Holdings
100.0%
Mar 31, 2026
Purchase
Shares
2,269
Price
$2.54
Total Value
$5.75K
Shares Held After
2,325
% of Holdings
97.6%

Processa Pharmaceuticals, Inc. (PCSA)

Bigora Sian — Chief Development Officer
Mar 31, 2026
Purchase
Shares
2,107
Price
$2.54
Total Value
$5.34K
Shares Held After
3,711
% of Holdings
56.8%
Mar 31, 2026
Purchase
Shares
1,160,000
Price
$3.45
Total Value
$4.00M
Shares Held After
13,160,000
% of Holdings
8.8%
Mar 31, 2026
Purchase
Shares
150,000
Price
$20.00
Total Value
$3.00M
Shares Held After
2,359,025
% of Holdings
6.4%
Mar 31, 2026
Purchase
Shares
5,000
Price
$12.62
Total Value
$63.10K
Shares Held After
20,001
% of Holdings
25.0%

CURIS INC (CRIS)

KAITIN KENNETH I — Director
Mar 31, 2026
Purchase
Shares
10,000
Price
$0.55
Total Value
$5.49K
Shares Held After
11,407
% of Holdings
87.7%
Mar 31, 2026
Purchase
Shares
15,000
Price
$2.04
Total Value
$30.60K
Shares Held After
21,246
% of Holdings
70.6%
Mar 31, 2026
Purchase
Shares
34,000
Price
$19.31
Total Value
$656.54K
Shares Held After
1,726,039
% of Holdings
2.0%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%
Mar 30, 2026
Purchase
Shares
370
Price
$27.68
Total Value
$10.24K
Shares Held After
145,678
% of Holdings
0.3%
Mar 30, 2026
Purchase
Shares
1,176
Price
$26.70
Total Value
$31.40K
Shares Held After
145,678
% of Holdings
0.8%
Mar 30, 2026
Purchase
Shares
4,995
Price
$25.99
Total Value
$129.82K
Shares Held After
145,678
% of Holdings
3.4%
Mar 30, 2026
Purchase
Shares
2,992
Price
$25.08
Total Value
$75.03K
Shares Held After
145,678
% of Holdings
2.1%
Mar 30, 2026
Purchase
Shares
1,753
Price
$3.15
Total Value
$5.52K
Shares Held After
61,555
% of Holdings
2.8%
Mar 30, 2026
Purchase
Shares
2,000
Price
$17.08
Total Value
$34.16K
Shares Held After
15,500
% of Holdings
12.9%
Mar 30, 2026
Purchase
Shares
445
Price
$112.30
Total Value
$49.97K
Shares Held After
187,616
% of Holdings
0.2%
Mar 30, 2026
Purchase
Shares
20,000
Price
$18.23
Total Value
$364.60K
Shares Held After
1,692,039
% of Holdings
1.2%
Mar 30, 2026
Purchase
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%
Mar 30, 2026
Purchase
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%
Mar 30, 2026
Purchase
Shares
971,091
Price
$6.50
Total Value
$6.31M
Shares Held After
26,975,505
% of Holdings
3.6%
Mar 27, 2026
Purchase
Shares
294
Price
$28.13
Total Value
$8.27K
Shares Held After
142,360
% of Holdings
0.2%
Mar 27, 2026
Purchase
Shares
4,384
Price
$27.28
Total Value
$119.61K
Shares Held After
142,360
% of Holdings
3.1%
Mar 27, 2026
Purchase
Shares
10,643
Price
$26.29
Total Value
$279.84K
Shares Held After
142,360
% of Holdings
7.5%
Mar 27, 2026
Purchase
Shares
310,700
Price
$23.67
Total Value
$7.35M
Shares Held After
5,767,221
% of Holdings
5.4%

Immunome Inc. (IMNM)

SIEGALL CLAY B — Director
Mar 27, 2026
Purchase
Shares
25,450
Price
$19.67
Total Value
$500.60K
Shares Held After
690,704
% of Holdings
3.7%
Mar 27, 2026
Purchase
Shares
2,495,623
Price
$6.43
Total Value
$16.05M
Shares Held After
26,004,414
% of Holdings
9.6%

LENZ Therapeutics, Inc. (LENZ)

Chevallard Daniel R. — Chief Financial Officer
Mar 27, 2026
Purchase
Shares
7,500
Price
$8.57
Total Value
$64.28K
Shares Held After
12,886
% of Holdings
58.2%
Mar 27, 2026
Purchase
Shares
5,592
Price
$8.92
Total Value
$49.89K
Shares Held After
5,592
% of Holdings
100.0%
Mar 27, 2026
Purchase
Shares
28,089
Price
$8.95
Total Value
$251.41K
Shares Held After
77,289
% of Holdings
36.3%
Mar 26, 2026
Purchase
Shares
1,025
Price
$29.98
Total Value
$30.73K
Shares Held After
131,370
% of Holdings
0.8%
Mar 26, 2026
Purchase
Shares
2,601
Price
$28.85
Total Value
$75.05K
Shares Held After
131,370
% of Holdings
2.0%
Mar 26, 2026
Purchase
Shares
1,327
Price
$27.95
Total Value
$37.09K
Shares Held After
131,370
% of Holdings
1.0%
Mar 26, 2026
Purchase
Shares
778
Price
$27.23
Total Value
$21.18K
Shares Held After
131,370
% of Holdings
0.6%
Mar 26, 2026
Purchase
Shares
351,224
Price
$6.38
Total Value
$2.24M
Shares Held After
23,508,791
% of Holdings
1.5%
Version: v26.5.2